Trial Outcomes & Findings for Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation (NCT NCT07297719)

NCT ID: NCT07297719

Last Updated: 2026-08-19

Results Overview

Glistening count: Number of glistenings (=microvacuoles) in the illuminated field were counted by slit lamp examination at the study visit 24 months post IOL implantation of the study eye. Lower glistening counts indicate a better outcome (=fewer glistenings).

Recruitment status

COMPLETED

Target enrollment

33 participants

Primary outcome timeframe

single study visit conducted 24 months after IOL implantation of the study eye

Results posted on

2026-08-19

Participant Flow

Participant milestones

Participant milestones
Measure
IOL CT LUCIA 621P
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
Overall Study
STARTED
33
Overall Study
COMPLETED
33
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation
Age, Categorical
<=18 years
0 Participants
n=298 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
n=298 Participants
Age, Categorical
>=65 years
29 Participants
n=298 Participants
Age, Continuous
73.2 Years
STANDARD_DEVIATION 7.0 • n=298 Participants
Sex: Female, Male
Female
20 Participants
n=298 Participants
Sex: Female, Male
Male
13 Participants
n=298 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=298 Participants
Race (NIH/OMB)
Asian
33 Participants
n=298 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=298 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=298 Participants
Race (NIH/OMB)
White
0 Participants
n=298 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=298 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=298 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=298 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
33 Participants
n=298 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=298 Participants
Race/Ethnicity, Customized
Nationality · Han Nationality
33 Participants
n=298 Participants
Race/Ethnicity, Customized
Nationality · Other Nationality
0 Participants
n=298 Participants
Region of Enrollment
China
33 Participants
n=298 Participants
Corrected distance visual acuity
0.54 logMAR
STANDARD_DEVIATION 0.21 • n=298 Participants

PRIMARY outcome

Timeframe: single study visit conducted 24 months after IOL implantation of the study eye

Glistening count: Number of glistenings (=microvacuoles) in the illuminated field were counted by slit lamp examination at the study visit 24 months post IOL implantation of the study eye. Lower glistening counts indicate a better outcome (=fewer glistenings).

Outcome measures

Outcome measures
Measure
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
Glistening Count
0 MV
Standard Deviation 0

PRIMARY outcome

Timeframe: single study visit conducted 24 months after IOL implantation of the study eye

Glistening density evaluation: Number of glistenings in the illuminated field were counted by slit lamp examination at the study visit 24 months post IOL implantation of the study eye. The number of glistenings were recorded and the density of microvacuoles per square millimeter (MV/mm²) was calculated. Lower glistening density values indicate better outcome (=fewer glistenings).

Outcome measures

Outcome measures
Measure
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
Glistening Density Evaluation
0 MV/mm²
Standard Deviation 0

PRIMARY outcome

Timeframe: single study visit conducted 24 months after IOL implantation of the study eye

Glistening grading (Miyata classification): At the 24-month post-IOL implantation visit, the number of glistenings/microvacuoles (MV) in the illuminated field of the study eye was counted by slit-lamp examination. Glistening density was expressed as microvacuoles per square millimeter (MV/mm²) and graded using the Miyata Glistening Density Grading Scale (grades 0-3), where the minimum glistening level corresponds to grade 0 (\<25 MV/mm²) and the maximum to grade 3 (101-200 MV/mm²).0 corresponds to \<25 MV/mm² and grade 3 to 101-200 MV/mm². Lower Miyata grades indicate a better outcome (=fewer glistenings).

Outcome measures

Outcome measures
Measure
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
Glistening Grading (Miyata Classification)
0 Scores on a scale
Standard Deviation 0

PRIMARY outcome

Timeframe: single study visit conducted 24 months after IOL implantation of the study eye

Monocular Corrected Distance Visual Acuity (CDVA) was assessed for each study eye using a standardized visual acuity chart under photopic conditions with the subject's best refractive correction in place. CDVA was recorded in logarithm of the Minimum Angle of Resolution (logMAR), with typical values ranging from about -0.3 (approximately 20/10 Snellen acuity) to 1.0 (approximately 20/200 Snellen acuity), where lower logMAR scores indicate better vision.

Outcome measures

Outcome measures
Measure
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
Monocular Corrected Distance Visual Acuity (CDVA)
0.043 logMAR
Standard Deviation 0.098

OTHER_PRE_SPECIFIED outcome

Timeframe: single study visit conducted 24 months after IOL implantation of the study eye

Subjective (manifest) refraction was performed under photopic conditions using standardized logarithmic visual acuity charts. For each study eye, manifest refraction was conducted to determine the best refractive correction. Sphere, cylinder, and axis were recorded, and spherical equivalent (SE) was calculated. SE values are reported in diopters (D). SE values closer to 0.00 D indicate a better refractive outcome (i.e., less residual myopia or hyperopia or astigmatism). An SE value within approximately ±0.50 D is generally considered a good refractive result.

Outcome measures

Outcome measures
Measure
IOL CT LUCIA 621P
n=33 Participants
Observational study conducted 24 months after cataract surgery and CT LUCIA 621P intraocular lens implantation; no new implantations of the CT LUCIA 621P IOL are performed as part of this study.
Subjective Refraction (Spherical Equivalent)
-0.170 D (Diopter)
Standard Deviation 0.608

Adverse Events

IOL CT LUCIA 621P

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

CZM Clinical Affairs

Carl Zeiss Meditec AG

Phone: +49 30 8540010

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60